Precision Biosciences DTIL
NASDAQ DTIL
$8.85 +0.13 (+1.43%)
As of: Aug 21, 2026 · 3:59 PM EDT

Precision Biosciences (DTIL) Net Margin (QoQ) (2018 - 2026)

Precision Biosciences (DTIL) Net Margin (QoQ) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Precision Biosciences 228.31 Mn 140.77 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -11,713.00
Dec 31, 2025 21.27 Mn
Sep 30, 2025 -8.95 Mn
Jun 30, 2025 -4.98 Mn
Mar 31, 2025 -6.96 Mn
Dec 31, 2024 137,327.00
Sep 30, 2024 -514,647.00
Jun 30, 2024 4,881.00
Mar 31, 2024 2,295.00
Dec 31, 2023 -7,129.00
Sep 30, 2023 7,549.00
Jun 30, 2023 8,178.00
Mar 31, 2023 -4,104.00
Dec 31, 2022 2,662.00
Sep 30, 2022 82,671.00
Jun 30, 2022 9,310.00
Mar 31, 2022 -54,740.00
Dec 31, 2021 -39,249.00
Sep 30, 2021 -12,044.00
Jun 30, 2021 14,679.00